Neurelis

About:

Neurelis is a specialty pharmaceutical company providing a highly differentiated approach to target unmet medical needs.

Website: http://www.neurelis.com/

Twitter/X: neurelisinc

Top Investors: Cormorant Asset Management, Decheng Capital, HBM Healthcare Investments, LYZZ Capital, Philos & Partners

Description:

Neurelis is a specialty pharmaceutical company, licenses, develops, and commercializes product candidates for epilepsy and the broader central nervous system (CNS) market. It provides a differentiated approach to target unmet medical needs. Their application of novel technologies is designed to enhance the therapeutic benefit and patient care. The company was incorporated in 2007 and is based in Encinitas, California.